Flupirtine and antihistamines exert synergistic anti-nociceptive effects in mice
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature..
RATIONALE: Drug combinations are commonly used in pain management, which can produce potent analgesic effects with reduced dosage and adverse effects.
OBJECTIVE: This study was designed to evaluate the anti-nociceptive effects and adverse effects of new combinations of flupirtine (a Kv7 potassium channel opener) and antihistamines (promethazine, fexofenadine) on acute and chronic pain in mice, and the possible mechanisms behind the synergistic analgesic effects were preliminarily investigated.
METHODS: In acetic acid writhing test, carrageenan-induced inflammatory pain model, and paclitaxel-induced neuropathic pain model, the interaction indexes (γ) between flupirtine and antihistamines were determined by isobolographic analysis. Furthermore, the Kv7 channel blocker XE991 was used to determine whether the effects of single agents and drug combinations on paclitaxel- and carrageenan-induced mechanical allodynia were mediated by Kv7 channels. Finally, hepatotoxicity markers, liver histopathology, and the rotarod test were used to investigate the adverse effects of drugs in combination doses.
RESULTS: The interaction indexes of flupirtine-promethazine and flupirtine-fexofenadine in all the above three pain models were lower than 1. The analgesic effects of flupirtine (13 mg/kg), promethazine (5 mg/kg), fexofenadine (20 mg/kg), and their combinations were antagonized significantly by XE991 (3 mg/kg). And the adverse effects of flupirtine and antihistamines in combination doses were not significantly different from the vehicle group.
CONCLUSIONS: Flupirtine and antihistamines produced synergistic analgesic effects in all the above pain models. The analgesic effects of antihistamines were partially mediated by Kv7/M channels, and the activation of Kv7/M channels may be partly responsible for the synergistic analgesic effects between flupirtine and antihistamines.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:240 |
|---|---|
| Enthalten in: |
Psychopharmacology - 240(2023), 4 vom: 05. Apr., Seite 881-897 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chen, Yanming [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 14.03.2023 Date Revised 14.03.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00213-023-06329-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM35262714X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35262714X | ||
| 003 | DE-627 | ||
| 005 | 20231226054147.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00213-023-06329-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1175.xml |
| 035 | |a (DE-627)NLM35262714X | ||
| 035 | |a (NLM)36752814 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chen, Yanming |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Flupirtine and antihistamines exert synergistic anti-nociceptive effects in mice |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.03.2023 | ||
| 500 | |a Date Revised 14.03.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. | ||
| 520 | |a RATIONALE: Drug combinations are commonly used in pain management, which can produce potent analgesic effects with reduced dosage and adverse effects | ||
| 520 | |a OBJECTIVE: This study was designed to evaluate the anti-nociceptive effects and adverse effects of new combinations of flupirtine (a Kv7 potassium channel opener) and antihistamines (promethazine, fexofenadine) on acute and chronic pain in mice, and the possible mechanisms behind the synergistic analgesic effects were preliminarily investigated | ||
| 520 | |a METHODS: In acetic acid writhing test, carrageenan-induced inflammatory pain model, and paclitaxel-induced neuropathic pain model, the interaction indexes (γ) between flupirtine and antihistamines were determined by isobolographic analysis. Furthermore, the Kv7 channel blocker XE991 was used to determine whether the effects of single agents and drug combinations on paclitaxel- and carrageenan-induced mechanical allodynia were mediated by Kv7 channels. Finally, hepatotoxicity markers, liver histopathology, and the rotarod test were used to investigate the adverse effects of drugs in combination doses | ||
| 520 | |a RESULTS: The interaction indexes of flupirtine-promethazine and flupirtine-fexofenadine in all the above three pain models were lower than 1. The analgesic effects of flupirtine (13 mg/kg), promethazine (5 mg/kg), fexofenadine (20 mg/kg), and their combinations were antagonized significantly by XE991 (3 mg/kg). And the adverse effects of flupirtine and antihistamines in combination doses were not significantly different from the vehicle group | ||
| 520 | |a CONCLUSIONS: Flupirtine and antihistamines produced synergistic analgesic effects in all the above pain models. The analgesic effects of antihistamines were partially mediated by Kv7/M channels, and the activation of Kv7/M channels may be partly responsible for the synergistic analgesic effects between flupirtine and antihistamines | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Analgesia | |
| 650 | 4 | |a Antihistamines | |
| 650 | 4 | |a Flupirtine | |
| 650 | 4 | |a Isobolographic analysis | |
| 650 | 4 | |a Pain | |
| 650 | 4 | |a Synergistic interaction | |
| 650 | 7 | |a Analgesics |2 NLM | |
| 650 | 7 | |a flupirtine |2 NLM | |
| 650 | 7 | |a MOH3ET196H |2 NLM | |
| 650 | 7 | |a Promethazine |2 NLM | |
| 650 | 7 | |a FF28EJQ494 |2 NLM | |
| 650 | 7 | |a fexofenadine |2 NLM | |
| 650 | 7 | |a E6582LOH6V |2 NLM | |
| 650 | 7 | |a Carrageenan |2 NLM | |
| 650 | 7 | |a 9000-07-1 |2 NLM | |
| 650 | 7 | |a Aminopyridines |2 NLM | |
| 650 | 7 | |a Histamine Antagonists |2 NLM | |
| 700 | 1 | |a Xiao, Xinyi |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Chaonan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, Jin |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Huiling |e verfasserin |4 aut | |
| 700 | 1 | |a Qin, Huimin |e verfasserin |4 aut | |
| 700 | 1 | |a Bao, Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Zhuang, Tao |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Guisen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Psychopharmacology |d 1977 |g 240(2023), 4 vom: 05. Apr., Seite 881-897 |w (DE-627)NLM00009434X |x 1432-2072 |7 nnns |
| 773 | 1 | 8 | |g volume:240 |g year:2023 |g number:4 |g day:05 |g month:04 |g pages:881-897 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00213-023-06329-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 240 |j 2023 |e 4 |b 05 |c 04 |h 881-897 | ||